Clarivate

CLVT · NYSE

$1.78+$0.02 (+1.14%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $1.76

Latest news

Press releaseOct 15, 11:19 AM ETBusiness Wire
Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions
Press releaseOct 6, 4:15 PM ETPRNewswire
Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation
Press releaseSep 24, 8:15 AM ETPRNewswire
Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Press releaseSep 23, 4:15 PM ETPRNewswire
Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Press releaseSep 22, 7:30 AM ETPRNewswire
Clarivate to Report Third Quarter 2026 Results on November 3, 2026
Press releaseSep 17, 8:15 AM ETPRNewswire
Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Press releaseSep 17, 3:05 AM ETPRNewswire
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
Press releaseAug 6, 4:00 AM ETPRNewswire
Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
NewsJul 29, 5:06 PM ET
12 Industrials Stocks Moving In Wednesday's After-Market Session
NewsJul 29, 8:05 AM ET
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
Press releaseJul 29, 6:05 AM ETPRNewswire
Clarivate Appoints Michael Easton as Chief Financial Officer
Press releaseJul 29, 6:00 AM ETPRNewswire
Clarivate Reports Second Quarter 2026 Results
Press releaseJul 20, 3:00 AM ETPRNewswire
Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers
Press releaseJul 16, 3:00 AM ETPRNewswire
USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate
Press releaseJul 14, 3:02 AM ETPRNewswire
Clarivate Selected by Abes to Modernize French National Academic Library System
Press releaseJul 10, 8:00 AM ETPRNewswire
Clarivate to Report Second Quarter 2026 Results on July 29, 2026
NewsJul 6, 6:10 AM ET
Clarivate To Sell Its Life Sciences & Healthcare Unit To Altaris For $600M; Reaffirms FY2026 Guidance
Press releaseJul 6, 6:00 AM ETPRNewswire
Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million
NewsJul 2, 1:05 PM ET
12 Industrials Stocks Moving In Thursday's Intraday Session
Press releaseJun 23, 3:00 AM ETPRNewswire
Clarivate Releases 2025 Sustainability Report
Press releaseJun 17, 3:00 AM ETPRNewswire
Clarivate Releases Journal Citation Reports 2026
Press releaseJun 15, 3:00 AM ETPRNewswire
Clarivate's IPfolio Selected by Mitsubishi Fuso
Press releaseJun 8, 9:00 AM ETPRNewswire
Clarivate Announces Simon Webster as President of Intellectual Property Segment
Press releaseMay 29, 3:00 AM ETPRNewswire
Clarivate Introduces IPOne
Press releaseMay 21, 3:00 AM ETPRNewswire
Clarivate's IPfolio and Renewal Services Selected by IGT
Press releaseMay 19, 3:05 AM ETPRNewswire
Clarivate Selected By Czech National Library of Technology to Develop Unified National Library Platform
Press releaseMay 6, 3:00 AM ETPRNewswire
Clarivate launches Web of Science Research Intelligence
NewsApr 29, 1:05 PM ET
12 Industrials Stocks Moving In Wednesday's Intraday Session
NewsApr 29, 10:15 AM ET
Full Transcript: Clarivate Q1 2026 Earnings Call
NewsApr 29, 7:11 AM ET
Earnings Scheduled For April 29, 2026
NewsApr 29, 6:00 AM ET
Clarivate Q1 Adj. EPS $0.18 Beats $0.14 Estimate, Sales $585.500M Beat $569.496M Estimate.
Press releaseApr 29, 6:00 AM ETPRNewswire
Clarivate Reports First Quarter 2026 Results
Press releaseApr 28, 3:00 AM ETPRNewswire
Clarivate Introduces Nexus Connect, the First Institutional AI Gateway to Trusted Research and Learning
NewsMar 15, 9:20 AM ETLekha Gupta
Consumer Tech News (Mar 9-13): Trump Administration Sues California Over Emissions Targets, Nvidia Announces $26B AI Investment & More
NewsMar 10, 8:54 AM ETAkanksha Bakshi
Clarivate Brings Trusted Regulatory Intelligence To Claude's AI Ecosystem
NewsMar 10, 4:07 AM ET
Clarivate Brings Cortellis Regulatory Intelligence Into Claude Through Model Context Protocol To Accelerate Life Sciences Regulatory Decision-Making
Press releaseMar 10, 4:00 AM ETPRNewswire
Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude
NewsMar 4, 2:01 PM ET
Analyst Expectations For Clarivate's Future
Press releaseFeb 24, 6:00 AM ETPRNewswire
Clarivate Reports Fourth Quarter and Full Year 2025 Results
Press releaseFeb 9, 8:00 AM ETBusiness Wire
Impactive Capital Nominates Four Candidates to WEX Board
Press releaseFeb 3, 8:00 AM ETPRNewswire
Clarivate Webinar "Intelligence Amplified in the Age of AI" Highlights How Trusted, Proprietary Data Powers Next‑Generation Innovation
Press releaseJan 6, 3:07 AM ETPRNewswire
Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report
Press releaseOct 29, 6:00 AM ETPRNewswire
Clarivate Reports Third Quarter 2025 Results
Press releaseJul 30, 6:00 AM ETPRNewswire
Clarivate Reports Second Quarter 2025 Results
Press releaseApr 29, 6:00 AM ETPRNewswire
Clarivate Reports First Quarter 2025 Results
Press releaseFeb 19, 6:00 AM ETPRNewswire
Clarivate Reports Fourth Quarter and Full Year 2024 Results
Press releaseNov 6, 6:00 AM ETPRNewswire
Clarivate Reports Third Quarter 2024 Results
Press releaseAug 6, 6:00 AM ETPRNewswire
Clarivate Reports Second Quarter 2024 Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions

Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation

Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate to Report Third Quarter 2026 Results on November 3, 2026

Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

12 Industrials Stocks Moving In Wednesday's After-Market Session

12 Industrials Stocks Moving In Wednesday's Pre-Market Session

Clarivate Appoints Michael Easton as Chief Financial Officer

Clarivate Reports Second Quarter 2026 Results

Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers

USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate

Clarivate Selected by Abes to Modernize French National Academic Library System

Clarivate to Report Second Quarter 2026 Results on July 29, 2026

Clarivate To Sell Its Life Sciences & Healthcare Unit To Altaris For $600M; Reaffirms FY2026 Guidance

Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million

12 Industrials Stocks Moving In Thursday's Intraday Session

Clarivate Releases 2025 Sustainability Report

Clarivate Releases Journal Citation Reports 2026

Clarivate's IPfolio Selected by Mitsubishi Fuso

Clarivate Announces Simon Webster as President of Intellectual Property Segment

Clarivate Introduces IPOne

Clarivate's IPfolio and Renewal Services Selected by IGT

Clarivate Selected By Czech National Library of Technology to Develop Unified National Library Platform

Clarivate launches Web of Science Research Intelligence

12 Industrials Stocks Moving In Wednesday's Intraday Session

Full Transcript: Clarivate Q1 2026 Earnings Call

Earnings Scheduled For April 29, 2026

Clarivate Q1 Adj. EPS $0.18 Beats $0.14 Estimate, Sales $585.500M Beat $569.496M Estimate.

Clarivate Reports First Quarter 2026 Results

Clarivate Introduces Nexus Connect, the First Institutional AI Gateway to Trusted Research and Learning

Consumer Tech News (Mar 9-13): Trump Administration Sues California Over Emissions Targets, Nvidia Announces $26B AI Investment & More

Clarivate Brings Trusted Regulatory Intelligence To Claude's AI Ecosystem

Clarivate Brings Cortellis Regulatory Intelligence Into Claude Through Model Context Protocol To Accelerate Life Sciences Regulatory Decision-Making

Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude

Analyst Expectations For Clarivate's Future

Clarivate Reports Fourth Quarter and Full Year 2025 Results

Impactive Capital Nominates Four Candidates to WEX Board

Clarivate Webinar "Intelligence Amplified in the Age of AI" Highlights How Trusted, Proprietary Data Powers Next‑Generation Innovation

Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report

Clarivate Reports Third Quarter 2025 Results

Clarivate Reports Second Quarter 2025 Results

Clarivate Reports First Quarter 2025 Results

Clarivate Reports Fourth Quarter and Full Year 2024 Results

Clarivate Reports Third Quarter 2024 Results

Clarivate Reports Second Quarter 2024 Results